Café Croissant with Bloom Burton & Co. - 2021 Biotechnology Financing Year In Review and 2022 Preview

ContactMarie-Pierre Maltais
Café Croissant with Bloom Burton & Co. - 2021 Biotechnology Financing Year In Review and 2022 Preview

Café Croissant with Bloom Burton & Co.  

On December 8, discover the 2021 Biotech Funding Year in Review and 2022 Preview during this Café Croissant with Bloom Burton & Co. 

Event presented as part of the FISQ 2021 (more details to come)

Presentation in English

 

How was 2021 for Canadian and global biotech financings? Which companies performed and which did not? What can we learn from 2021 and predict for 2022? What are the biggest milestones and what can we learn from them?

Register for the final Café Croissant of 2021 to hear Brian Bloom and the Bloom Burton & Co. team present an overview of the Canadian capital markets.

 

Presented by: 

Brian Bloom
Co-founder, President and CEO

Brian Bloom is co-founder, Chairmanand CEO of Bloom Burton & Co. By forging unique relationships with international healthcare-specialized investors, Brian raises capital for Canadian healthcare companies while helping investors realize returns.

Brian serves on the Board of Directors of Triumvira Immunologics, Appili Therapeutics, Satellos Bioscience and Qing Bile Therapeutics. Brian is also on the Faculty of Science Dean’s Advisory Board at McMaster University.

 

Vincent Nadeau, Ph.D
Vice President, Investment Banking

Vincent Nadeau joined Bloom Burton & Co. in February 2015. He brings scientific, R&D, business, IP and regulatory insights and advice to healthcare companies, supporting their growth and the monetization of exciting life science technologies and products in Canada. Vincent’s expertise also supports newly formed Bloom Burton incubated companies, working with management teams to build value early on in their corporate life.

 

 

 

About Bloom Burton & Co.

Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies.  It is comprised of medical, scientific, pharmaceutical, financial, legal and capital markets professionals with extensive experience. Their broad expertise allows them to take a creative, innovative and entrepreneurial approach to helping their clients achieve the right monetization events.
 
Bloom Burton and its affiliates offer fundraising, M&A advisory, equity research, business strategy and scientific advisory, direct investment advisory, company formation and incubation services.

Learn more about Bloom Burton

 

Join us! 

Registration to be opened soon